Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:43:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no substantive study content changes are evident.
    Difference
    0.1%
    Check dated 2026-03-11T17:20:52.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and a notice about government funding was removed along with Revision: v3.4.1. These are administrative updates that do not affect study details or outcomes.
    Difference
    0.5%
    Check dated 2026-02-11T01:59:37.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A site-wide government funding notice banner was added and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:22:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a glossary toggle in the header and introduced metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision updated to v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria' (lowercase 'met'), 'No FEAR Act data', and the previous revision note v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:16:24.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-22T23:53:13.000Z thumbnail image

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.